Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2013
10/22/2013CA2707726C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/22/2013CA2550642C Oligonucleotide compound and method for treating nidovirus infections
10/22/2013CA2526720C Recombinant carrier molecule for expression, delivery and purification of target polypeptides
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2367750C Tribonectins
10/22/2013CA2359926C Antagonists of hmg1 for treating inflammatory conditions
10/17/2013WO2013155123A1 Compositions and methods for treating otitis media and other conditions with inhibitors of cyld
10/17/2013WO2013154760A1 Chimeric antigen receptors targeting b-cell maturation antigen
10/17/2013WO2013154128A1 Novel arteriosclerosis treatment drug composition and method for screening arteriosclerosis treatment drugs
10/17/2013WO2013123432A3 Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
10/17/2013US20130276158 Methods and compositions for rna interference
10/17/2013US20130274704 Augmented cognitive training
10/17/2013US20130274314 Mitochondrial targeted rna expression system and use thereof
10/17/2013US20130274309 Compositions and methods for non-parenteral delivery of oligonucleotides
10/17/2013US20130273652 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
10/17/2013US20130273142 Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to rna interference molecules
10/17/2013US20130273084 Use of a dna expression construct
10/17/2013US20130272998 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
10/16/2013EP2650383A1 Ultraconserved regions encoding ncRNAs
10/16/2013EP2650018A2 Antibody-LIGHT fusion products for cancer therapeutics
10/16/2013EP2648763A2 Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
10/16/2013EP2648762A2 Post-treatment breast cancer prognosis
10/16/2013EP2648761A1 Cancer gene therapy using nucleic acids encoding us28 and g-protein
10/16/2013EP2648756A2 Targeting kidney mesangium with nanoparticles of defined diameter
10/16/2013CN103354750A Consensus antigen constructs and vaccines made there form, and methods of using same to treat malaria
10/16/2013CN103352051A PcDNA3.1(+)-Fbw7 (F-box and WD repeat domain-containing 7) recombinant plasmid as well as construction method and application of PcDNA3.1(+)-Fbw7 recombinant plasmid
10/16/2013CN103352047A Trichinella Spiralis larva ES antigen gene vaccine and preparation method
10/16/2013CN103352037A Aptamer therapeutics useful in the treatment of complement-related disorders
10/16/2013CN103352036A SiRNA molecule targeting tumor related genes and application thereof
10/16/2013CN103351423A Peptide vaccines for cancers expressing tumor-associated antigens
10/16/2013CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties
10/16/2013CN102690335B Polypeptide for effectively inhibiting activity of influenza virus polymerase
10/16/2013CN102286104B Gene for encoding HPV (human papilloma virus) 6-type L2N120E7E6 fusion protein, expression vectors, method, bacteria strain and application
10/16/2013CN102051362B Interference RNA (Ribonucleic Acid) of targeted HPIP (hematopoietic PBX-interacting protein) gene, medical composition containing same and application thereof
10/16/2013CN101873866B Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
10/15/2013US8557975 Methods and sequences to suppress primate Huntington gene expression
10/15/2013US8557788 Prevention of tissue ischemia and related compositions
10/15/2013US8557786 Micro RNA (MiRNA) and neurofibromatosis type 1: a role in diagnosis and therapy
10/15/2013US8557785 In vivo production of small interfering RNAS that mediate gene silencing
10/15/2013US8557515 Compositions and methods for cancer diagnosis and therapy
10/15/2013US8557289 Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle
10/15/2013US8557238 EG-VEGF nucleic acids and polypeptides and methods of use
10/15/2013US8557231 Biodegradable poly(beta-amino esters) and uses thereof
10/15/2013CA2634480C Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof
10/15/2013CA2452119C Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof
10/15/2013CA2296434C Mutations in the myostatin gene cause double-muscling in mammals
10/10/2013WO2013152291A1 Cell therapy technology to deliver radio-protective peptides
10/10/2013WO2013152230A1 Smooth muscle specific inhibition for anti-restenotic therapy
10/10/2013WO2013151999A1 Cancer treatment and immune system regulation through fat10 pathway inhibition
10/10/2013WO2013151981A1 Ewing's sarcoma bifunctional shrna design
10/10/2013WO2013151736A2 In vivo production of proteins
10/10/2013WO2013151677A1 Ddr2 mutations in cancer
10/10/2013WO2013151672A2 Modified polynucleotides for the production of oncology-related proteins and peptides
10/10/2013WO2013151668A2 Modified polynucleotides for the production of secreted proteins
10/10/2013WO2013151666A2 Modified polynucleotides for the production of biologics and proteins associated with human disease
10/10/2013WO2013151665A2 Modified polynucleotides for the production of proteins associated with human disease
10/10/2013WO2013151664A1 Modified polynucleotides for the production of proteins
10/10/2013WO2013151640A2 Additive for use in wash step of pet recycling process
10/10/2013WO2013151326A1 Method of preparing composition for delivering an anionic drug
10/10/2013WO2013122375A3 Pharmaceutical composition for viral treatment, and method for screening antiviral agent
10/10/2013WO2013103424A9 Silk-based multifunctional biomedical platform
10/10/2013US20130267028 Recombinant Influenza Viruses for Vaccines and Gene Therapy
10/10/2013US20130266610 Stimulating anti-tumor immune response and boosting cancer immunotherapy via expression of 15-pgdh
10/10/2013US20130266553 Albumin Fusion Proteins
10/09/2013EP2647713A1 Modified single-strand polynucleotide
10/09/2013EP2646556A2 Novel hybrid promoter and recombinant vector comprising the same
10/09/2013EP2646052A2 Lyophilized viral formulations
10/09/2013EP2646051A2 Liquid viral formulations
10/09/2013EP2646007A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
10/09/2013EP2359854B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
10/09/2013CN103347542A 免疫刺激性寡核苷酸 Immunostimulatory oligonucleotides
10/09/2013CN103347535A Liquid viral formulations
10/09/2013CN103347393A Oncolytic vaccinia virus combination cancer therapy
10/09/2013CN103343160A Novel purpose of microRNA-30 family
10/09/2013CN103343141A Restructured newcastle disease virus/genome plasmid for expressing humanized chimeric antibody cHAb18 and application thereof in anti-tumor treatment
10/09/2013CN103343125A shRNA for inhibiting colon cancer cell PRPS2 expression, construction method of vector of shRNA, and use of shRNA
10/09/2013CN103342789A Diblock copolymer for intracellular transmission and its polynucleotide compound
10/09/2013CN103342751A Antibody neutralizers of human granulocyte macrophage colony stimulating factor
10/09/2013CN103341179A Mucosa M-cell targeted viral myocarditis gene vaccine and preparation method thereof
10/09/2013CN103341159A Application of immune regulation markers TIPE2 (Tumor Necrosis Factor-a Induced Protein 8 like 2) in preparation of medicine used for treating vascular proliferation diseases
10/09/2013CN102649961B Aptamer sequence of hepatitis B virus (HBV) core antigen and application of nucleic aptamer sequence
10/09/2013CN102266569B Application of miR-199a and inhibitor thereof
10/09/2013CN102218145B Medicinal composition for protecting optic nerve of glaucoma and preparation method thereof
10/09/2013CN102198264B Beta-defensin 15 of specific antibacterial peptides of rat epididymis and application thereof
10/09/2013CN102174099B Target protein for Alzheimer's disease and coding gene and application thereof
10/09/2013CN101942442B Novel beta-actin and rps21 promoters and uses thereof
10/09/2013CN101005827B Articles for the delivery of therapeutic agents
10/08/2013US8552171 RNA sequence-specific mediators of RNA interference
10/08/2013US8552167 Multifunctional aptamer-nucleic acid nanostructures for tumor-targeted killing
10/08/2013US8552165 Immunostimulatory oligonucleotides
10/08/2013US8551971 Composition for treatment of pancreatic cancer
10/08/2013US8551970 Genetic suppression and replacement
10/08/2013US8551969 Methods to identify compounds useful for tumor sensitization to DNA damage
10/08/2013US8551968 Methods for generation of antibodies
10/08/2013US8551967 Formulations with anti-tumour action
10/08/2013US8551773 Methods and compositions relating to improved lentiviral vectors and their applications
10/08/2013US8551706 Identification of oligonucleotides for the capture, detection and quantitation of West Nile Virus
10/08/2013US8551699 PCA3, PCA3 genes, and methods of use
10/08/2013US8551490 Genetic products differentially expressed in tumors and use thereof
10/08/2013US8551472 Method of making macrophage expressing an antibody directed against β-amyloid
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 870